XTLB
XTL Biopharmaceuticals
XTLB
XTLB
6 hedge funds and large institutions have $405K invested in XTL Biopharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
Holders
6
Holders Change
+1
Holders Change %
+20%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BRWA
1
B. Riley Wealth Advisors
Boca Raton,
Florida
|
$1.22K |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$2K |
Top Sellers
| 1 |
U
1
UBS
Zurich,
Switzerland
|
$4K |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Invesco
Atlanta,
Georgia
| $397K | 25,962 | – | – |
|
|
U
2
UBS
Zurich,
Switzerland
| $4K | 253 | -79 | -24% |
|
|
TRCT
3
Tower Research Capital (TRC)
New York
| $2K | 147 | +47 | +47% |
|
|
BRWA
4
B. Riley Wealth Advisors
Boca Raton,
Florida
| $1.22K | 80 | +80 | New |
|
5
Ameriprise
Minneapolis,
Minnesota
| $1K | 88 | – | – |
|
6
Morgan Stanley
New York
| $0 | 1 | – | – |
|